These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 7067168

  • 1. Increased renal excretion of 3 hydroxyproline in patients with active glomerular nephropathies and with polycystic renal disease.
    Chanard J, Szymanowicz A, Brunois JP, Toupance O, Melin JP, Birembaut P, Randoux A, Borel PJ.
    Clin Nephrol; 1982 Feb; 17(2):64-9. PubMed ID: 7067168
    [Abstract] [Full Text] [Related]

  • 2. Urinary 3-hydroxyproline in renal disease.
    Chanard J, Szymanowicz A, Brunois JP, Toupance O, Birembaut P, Borel PJ.
    Ren Physiol; 1980 Feb; 3(1-6):163-8. PubMed ID: 7323410
    [Abstract] [Full Text] [Related]

  • 3. [Semeiological value of the electrophoretic analysis of urinary proteins].
    Traeger J, Manuel Y, Revillard JP, Friès D.
    Bull Mem Soc Med Hop Paris; 1967 Feb 10; 118(3):203-15. PubMed ID: 6058836
    [No Abstract] [Full Text] [Related]

  • 4. Increase urinary hepatocyte growth factor excretion in human acute renal failure.
    Taman M, Liu Y, Tolbert E, Dworkin LD.
    Clin Nephrol; 1997 Oct 10; 48(4):241-5. PubMed ID: 9352159
    [Abstract] [Full Text] [Related]

  • 5. Urinary excretion of protein and non-protein hydroxyproline in patients with sarcoidosis and interstitial pulmonary fibrosis.
    Podwysocki B, Zwoliński J, Szklarz E.
    Mater Med Pol; 1993 Oct 10; 25(1):13-6. PubMed ID: 8412335
    [Abstract] [Full Text] [Related]

  • 6. Urinalysis and clinical renal disease.
    Szwed JJ.
    Am J Med Technol; 1980 Oct 10; 46(10):720-5. PubMed ID: 7211937
    [Abstract] [Full Text] [Related]

  • 7. Thiamphenicol excretion in subjects with renal insufficiency.
    Azzollini F, Gazzaniga A, Lodola E.
    Int Z Klin Pharmakol Ther Toxikol; 1970 Oct 10; 3(4):303-8. PubMed ID: 5481994
    [No Abstract] [Full Text] [Related]

  • 8. Thiamphenicol excretion in subjects with renal insufficiency.
    Azzollini F, Gazzaniga A, Lodola E.
    Int Z Klin Pharmakol Ther Toxikol; 1970 Oct 10; 4(4):303-8. PubMed ID: 5494879
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N, Ogbori MR, Nicman E.
    Srp Arh Celok Lek; 2002 Oct 10; 130(7-8):251-7. PubMed ID: 12585002
    [Abstract] [Full Text] [Related]

  • 10. Excretion of Tamm-Horsfall glycoprotein in renal disease.
    Lynn KL, Marshall RD.
    Clin Nephrol; 1984 Nov 10; 22(5):253-7. PubMed ID: 6518675
    [Abstract] [Full Text] [Related]

  • 11. [Urinary excretion of alpha-1-microglobulin and complement components in patients with chronic glomerulonephritis].
    Niemir Z, Idasiak I, Ostrowski M, Polcyn M, Krzymański M.
    Przegl Lek; 1994 Nov 10; 51(8):333-8. PubMed ID: 7532869
    [Abstract] [Full Text] [Related]

  • 12. [The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].
    Idasiak-Piechocka I, Krzymański M.
    Przegl Lek; 1996 Nov 10; 53(5):443-53. PubMed ID: 8754411
    [Abstract] [Full Text] [Related]

  • 13. Non-diabetic renal disease in patients with type 2 diabetes mellitus.
    Prakash J, Sen D, Usha, Kumar NS.
    J Assoc Physicians India; 2001 Apr 10; 49():415-20. PubMed ID: 11762610
    [Abstract] [Full Text] [Related]

  • 14. [Effects of reduced glutathione on contents of hydroxyproline and oxidation stress reaction in kidney of unilateral ureteral obstruction in rat].
    Na Y, Zhang XX, Zhang XD, Yuan HP, Hu XL, Zheng W, Li G.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec 10; 19(12):735-8. PubMed ID: 18093431
    [Abstract] [Full Text] [Related]

  • 15. Interstitial nephritis, the nephrotic syndrome, and chronic renal failure secondary to nonsteroidal anti-inflammatory drugs.
    Kleinknecht D.
    Semin Nephrol; 1995 May 10; 15(3):228-35. PubMed ID: 7631049
    [Abstract] [Full Text] [Related]

  • 16. Urinary excretion of monocyte chemoattractant protein-1: a biomarker of active tubulointerstitial damage in patients with glomerulopathies.
    Dantas M, Romão EA, Costa RS, dos Reis MA, Vieira Neto OM, Ribeiro RA, Ravinal RC, Rodrigues Júnior AL, Coimbra TM.
    Kidney Blood Press Res; 2007 May 10; 30(5):306-13. PubMed ID: 17804911
    [Abstract] [Full Text] [Related]

  • 17. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B.
    Dan Med Bull; 1997 Apr 10; 44(2):191-207. PubMed ID: 9151012
    [Abstract] [Full Text] [Related]

  • 18. [Selectivity of urinary protein excretion in patients with chronic parenchymatous nephropathies].
    Rohrer T, Fischer L, Fuhrmann C, Hodler J.
    Schweiz Med Wochenschr; 1973 Jan 27; 103(4):131-40. PubMed ID: 4683727
    [No Abstract] [Full Text] [Related]

  • 19. Is morning urinary protein/creatinine ratio a reliable estimator of 24-hour proteinuria in patients with glomerulonephritis and different levels of renal function?
    Morales JV, Weber R, Wagner MB, Barros EJ.
    J Nephrol; 2004 Jan 27; 17(5):666-72. PubMed ID: 15593033
    [Abstract] [Full Text] [Related]

  • 20. [Lipiduria in the nephrotic syndrome].
    Neverov NI, Nikitina EA.
    Ter Arkh; 1992 Jan 27; 64(6):16-8. PubMed ID: 1440328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.